Clinical Trials Browser

Skin Neoplasms

Skin Neoplasms, Carcinoma, Merkel Cell

Neoplasm Metastasis, Skin Neoplasms, Carcinoma, Merkel Cell

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Carcinoma, Carcinoma, Basal Cell, Neoplasms, Skin Neoplasms

Carcinoma, Squamous Cell, Keratoacanthoma, Skin Neoplasms

Melanoma, Neoplasms, Skin Neoplasms

Skin Neoplasms, Carcinoma, Merkel Cell

Carcinoma, Squamous Cell, Neoplasm Metastasis, Skin Neoplasms

Melanoma, Neoplasms, Skin Neoplasms

Head and Neck Neoplasms, Skin Neoplasms

Carotid Intimal Medial Thickness 1, Carcinoma, Squamous Cell, Skin Neoplasms

Ectropion, Skin Neoplasms

Melanoma, Neoplasm Metastasis, Skin Neoplasms

Melanoma, Skin Neoplasms

Uveal Melanoma, Eye Neoplasms, Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Skin Neoplasms

Carcinoma, Basal Cell, Skin Neoplasms

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Skin Neoplasms

Carcinoma, Basal Cell, Skin Neoplasms

Melanoma, Skin Neoplasms

Skin Neoplasms

Melanoma, Neoplasm Metastasis, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Neoplasms, Skin Neoplasms

Skin Neoplasms

Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Neoplasms, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

Melanoma, Skin Neoplasms

Skin Neoplasms

Melanoma, Melanoma, Experimental, Neoplasms, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Clinical Trials

Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer

Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma

Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma

Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...

Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

Study of TVEC in Patients With Cutaneous Squamous Cell Cancer

A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma

Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma

Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma

Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma

Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma

Preventing Squamous Cell Skin Cancer

5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts

Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma

Lapatinib in Stage IV Melanoma With ERBB4 Mutations

Melanoma Vaccine With Peptides and Leuprolide

A Study of Glembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma

Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer

BOLT

Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma

Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas

A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma

Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin

Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma

Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Drosophila-generated CTL

Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin

Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection

Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation

Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma

Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma

Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma

Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma

Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells

Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M...

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma

ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin

Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma

Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes

Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma